Medicines in Development for Women 2013 Report

America's pharmaceutical research and biotechnology companies are developing 851 medicines for diseases that disproportionately affect American women. 
The medicines in the pipeline for women (either in clinical trials or awaiting review by the Food and Drug Administration) include:

  • 139 for cancers affecting women, including 91 for breast cancer, 49 for ovarian cancer and nine for cervical cancer.

  • 114 for arthritis/musculoskeletal disorders. Approximately 46 million Americans have some type of arthritis or related condition, and 60 percent of them are female.

  • 64 for obstetric/gynecologic conditions.

  • 110 for autoimmune diseases, which strike women three times more than men.

  • 72 for depression and anxiety. Almost twice as many women as men suffer from these disorders.

  • 83 for Alzheimer’s disease. Two-thirds (3.4 million) of the 5.4 million Americans living with Alzheimer’s today are women.

America’s pharmaceutical research and biotechnology companies continue making exciting progress in the search for new cures and treatments for diseases of special concern to women. We live in an era when we understand more about the difference between the sexes and their healthcare needs. This knowledge is inspiring a continuing medical revolution that is bringing new hope to women around the world.

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.